Pritelivirmesylate is active against herpes simplex virus types 1 and 2 (IC50: 0.02 μM against HSV1-2). Pritelivirmesylate is an inhibitor of the viral helicase-primase complex. Pritelivirmesylate shows antiviral activity in vitro and in animal models
Pritelivirmesylate hydrate is active against herpes simplex virus types 1 and 2 (IC50: 0.02 μM against HSV1-2). Pritelivirmesylate hydrate is an inhibitor of the viral helicase-primase complex. Pritelivirmesylate hydrate shows antiviral activity in vit